Stay updated on Adaptive Dosing of Ipilimumab and Nivolumab Clinical Trial
Sign up to get notified when there's something new on the Adaptive Dosing of Ipilimumab and Nivolumab Clinical Trial page.

Latest updates to the Adaptive Dosing of Ipilimumab and Nivolumab Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedRevision: v3.6.4 was added and Revision: v3.6.3 was removed, indicating a platform/software update for the page. This appears to be a templating or system update with no visible changes to the study content.SummaryDifference0.1%

- Check21 days agoNo Change Detected
- Check28 days agoNo Change Detected
- Check35 days agoChange DetectedRevision updated from v3.6.2 to v3.6.3, indicating a new revision release. This reflects a small administrative update to the page's revision history rather than changes to study content.SummaryDifference0.1%

- Check42 days agoChange DetectedThe page now shows Revision: v3.6.2, updating the revision tag to reflect a software update rather than a change to study details.SummaryDifference0.1%

- Check57 days agoChange DetectedRecruitment status updated to 'No longer looking for participants', indicating the study is not enrolling. New help/navigation sections were added ('How to Read a Study Record', 'Common Questions', 'How to Join a Study'), the Intervention/Treatment heading was added (replacing the old 'Intervention / Treatment' heading), and the revision line was updated to 'Revision: v3.6.0'.SummaryDifference0.4%

- Check64 days agoChange DetectedA new revision label (v3.5.5) replaces the previous v3.5.4 on the study page, indicating an update to the record's metadata.SummaryDifference0.1%

- Check85 days agoChange DetectedThe revision label on the page was updated from v3.5.3 to v3.5.4, signaling a minor update to the site’s underlying tooling or documentation rather than to trial content.SummaryDifference0.1%

Stay in the know with updates to Adaptive Dosing of Ipilimumab and Nivolumab Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Adaptive Dosing of Ipilimumab and Nivolumab Clinical Trial page.